GME Meeting Planner
This satellite symposium will provide an opportunity for the issues facing the field to be discussed and new strategies to improve outcomes for patients.
Satellite webcast symposium on the occasion of the 33rd ECNP Congress with educational financial support provided by Sunovion and Sumitomo Dainippon Pharma / Global Medical Education.
This live virtual CME webcast is open to all attendees of the 33rd ECNP Congress. This session offers 2 CME credits. Online registration is not available, but ECNP attendees are welcome to join us online. For more information or to register for the ECNP, please viist their website at: https://www.ecnp.eu/Congress2020/ECNPcongress
Schizophrenia is a leading cause of disability and premature mortality in the world. There are major unmet needs in schizophrenia that are not addressed by current antipsychotic treatment. Moreover, antipsychotic drugs are ineffective or not tolerated in two thirds of patients with schizophrenia. This symposium aims to consider the challenges facing the field, and provide a cutting-edge update on the latest developments in the treatment of schizophrenia informed by advances in understanding of the neurobiology underlying the disorder.
17:30 - 17:35 Opening Remarks
17:35 - 17:55: Unmet Needs in the Treatment of Schizophrenia: Ingrid Melle MD (University of Oslo)
17:55 - 18:15: Innovative Targets for Drug Discovery for Schizophrenia: Rachel Upthegrove MBBS FRCPsych PhD (Univ of Birmingham)
18:15 - 18:35 : Current and Emerging Treatments for Schizophrenia: Oliver Howes MD (Kings College London)
18:35 - 18:55: Q&A
18:55 - 19:00: Closing Remarks
Faculty Members Scheduled to Attend
Location and Date
GME is not taking registrations for this meeting. Please visit the ECNP's website for more information or to register: https://www.ecnp.eu/Congress2020/ECNPcongress